p. 10659−10668
2345-5055
Vol.8/No.1
p. 10669−10679
2345-5055
Vol.8/No.1
p. 10681−10688
2345-5055
Vol.8/No.1
p. 10689−10704
2345-5055
Vol.8/No.1
p. 10705−10709
2345-5055
Vol.8/No.1
p. 10711−10717
2345-5055
Vol.8/No.1
0.05). Staph positive culture was 20%; 18.9%, and 16.8%, respectively (p> 0.05). Pseudomonas aeruginosa was the most sensitive to vancomycin (93.8%), followed by colistin (93.3%) and ceftazidime (65.2%). There was no correlation between patients' age and multidrug resistance (MDR). FEV1 was significantly lower in both the patient with positive pseudomonas (p-value: 0.01), and culture and MDR (p= 0.023). Furthermore, in terms of antibiotic resistance over time, resistance to colistin statistically decreased from 25% in 2014 to 2% in 2018 (p= 0.02). Conclusion: Vancomycin, Colistin, Ceftazidim, Imipenem, Amikacin, and Gentamycin had the highest drug sensitivity; while Cefotaxime, Clindamycin, and Chloramphenicol antibiotics had a low sensitivity. From 2014 to 2019, resistance to Colistin dramatically decreased.]]>
p. 10719−10729
2345-5055
Vol.8/No.1
0.05). A significant increase in the percentage of Th1 cells was recorded in group A compared to group B (p= 0.02). CTL enhancement percentage was significantly increased in group A compared to group B after 2 months (p=0.013). Conclusion: Subcutaneous Immunotherapy concomitant with synbiotics administration may have temporarily increased the percentage of Th1 cells, but no significant clinical differences were observed.]]>
p. 10731−10742
2345-5055
Vol.8/No.1
p. 10743−10747
2345-5055
Vol.8/No.1
p. 10749−10757
2345-5055
Vol.8/No.1
p. 10759−10766
2345-5055
Vol.8/No.1
p. 10767−10773
2345-5055
Vol.8/No.1
0.05). The mean frequency and the duration of BHS decreased from 8.2 ± 4.3 to 1.6 ± 2.4 times per week (p = 0.000), and from 50.66 ± 26.26 to 5.4 ± 6 seconds (p = 0.000) in the control group; and from 7.2 ± 3 to 2.06 ± 2.7 times per week (p = 0.001), and 50.66 ± 38 to 8.8 ± 7.9 seconds (p = 0.002) in the intervention group, which was indicative of a statistically significant difference. However, the difference in the mean frequency and duration of BHS in the intervention group, which represents the effect of fluoxetine, was not statistically significant (p = 0.411 and p = 0.792, respectively). Conclusion: The results of the present research confirm the effect of iron therapy on decreasing the mean frequency and duration of BHS, but also indicate the ineffectiveness of synergistic administration of fluoxetine and iron on decreasing mean frequency and duration of BHS.]]>
p. 10775−10783
2345-5055
Vol.8/No.1
p. 10785−10799
2345-5055
Vol.8/No.1
p. 10781−10788
2345-5055
Vol.8/No.1
p. 10789−10798
2345-5055
Vol.8/No.1
p. 10799−10806
2345-5055
Vol.8/No.1
p. 10807−10815
2345-5055
Vol.8/No.1